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Abstract Interstitiallungdisease, althoughofprognostic impact forpatientswithcystic ¢brosis (CF), remainsdi⁄cult
to assesswithouthistopathologic investigations.Aschangesofperipheralbloodlymphocyte subsets (LS)mayaccompany
severe systemic lymphocyte immuneresponses, we comparedperipheral LS of 44 patientswith CF, 23 non-CF patients
with recurrent pulmonary infections and 83 healthy controls (£ow cytometry; CD3, CD19, CD16, CD56, CD4, CD8,
CD11b,CD45RA,CD45RO,HLA-DR and CD25 antigens). Additional immunohistochemistry was performed on lung
tissue of four CF patients aged 0?5,12,17 and 20 years, respectively. Patients with CF showed low absolute counts of
CD4+CD45RO+memoryhelperT cells,CD16+CD56+NKcells,CD8+ andinterleukin-2 receptor-positiveT cellsinperiph-
eralblood (Po0?001).Similar changeswereregistered inthenon-CF patientswith pulmonaryinfections, indicating that
those were not speci¢c for CF. Immunohistochemistry showed activation of bronchus-associated lymphoid tissue with
interstitial accumulationof CD4+CD45RO+ T cells inthe three olderpatients.Patientswith CF showmarkedchanges of
peripheral blood LSwhich are presumably not CF-speci¢c andmaymirror homing to lung tissue in the course of inter-
stitial lung disease.Further research should evaluate its usefulness inmonitoring progression of lung disease in CF.r2001
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Lung disease in cystic ¢brosis (CF) is a multi-factorial
process characterized by defective airway clearance of
microorganisms, especially of Pseudomonas aeruginosa,
due to impaired mucociliary clearance, altered function
of the respiratory epithelium and, possibly, reduced in-
nate immune defense. Simultaneously there is enhanced
intrabronchial antimicrobial immune defense with neu-
trophils playing a central role: they fail to clear the air-
ways of pathogens but, together with monocytes and
airwayepithelial cells, produce chemokines, exoenzymes
and reactive oxygen specimens which enhance the in-
£ammatory response and directly destroy lung tissue
(1^3). Lymphocytes contribute to this process, too. Pul-
monary interstitial T- and B cell in¢ltrations are present
from early infancy, presumably leading to aTh2-type in-
£ammatory response with increased interleukin-6 con-Received1March 2001, accepted in revised form11September 2001and
published online10 December 2001.
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E-mail: Haeusler@RWTH-Aachen.decentrations in bronchoalveolar lavage £uid, sputum,
plasma and trachealgland secretions, aswell as increased
synthesis of interleukin-4 and decreased synthesis of in-
terferon-gamma by peripheral blood mononuclear cells
(3^9).This interstitial in£ammationmay be related to al-
lergic pulmonary complications, to hypergammaglobuli-
nemia, to allergic bronchopulmonary aspergillosis, and
to acute bronchiolitis obliterans organizing pneumonia,
andmay even shorten survival (8,10^12).
Compared with neutrophils and the intrabronchial
compartment, knowledge on the lymphocyte system
and on interstitial pneumonia in CF is limited. On the
one hand, immunophenotyping of lymphocyte subsets
(LS) in lung tissue has been performed very rarely (5)
and lymphocyte analysis in bronchoalveolar lavage £uid
is limited by the abundance of neutrophils in bronchial
secretions.On the other hand, peripheralblood lympho-
cyte phenotyping, which mirrors immune function in
various in£ammatory diseases, has revealed contradic-
tory results, showing an increased or normal CD4/CD8
ratio and decreased or normal relative CD4+ and CD8+
cell counts (10,13^16). These latter studies, however,
were con¢ned to only few LS and to a small number
of patients. We hypothesized that a more extensive
88 RESPIRATORYMEDICINEanalysis might demonstrate hitherto unknown changes
of peripheral blood LS, characteristic of the in£amma-
tory response in CF.
PATIENTSANDMETHODS
Patients
Over a 5-year period we prospectively performed lym-
phocyte phenotyping from peripheral blood lympho-
cytes of 56 patients with CF (1ml EDTA). For data
analysis, patients not undergoing inhalative or systemic
corticosteroid therapy and with no allergic bronchopul-
monary aspergillosis or acute pulmonary in£ammation
were selected. Finally, data of 44 patients (age: 1month
^36 years, 12 males) were available for evaluation, and
the most recent investigation of each patient was se-
lected.The datawere comparedwith those of 83 healthy
controls (age:1month^29 years, 47males) prospectively
measured during the same period of time and of 23 in-
fants and children routinely investigated in our out-
patient clinic because of severe recurrent bronchopul-
monary infections (age: 4 months^8 years, 14 males).
The healthy controls belonged to the hospital sta¡ or
were attending the outpatient clinic for routine check-
ups.None had a history of recent or recurrent infections
or allergic diseases, or was receiving acute or chronic
medical treatment. Informedconsentwas givenby all pa-
tients or parents.The study was approved by the Ethics
Committee of the University.
Histopathology was performed on lung tissue from
four patients with CF: a 6-month-old infant (patient 1)
who had died from left heart failure in the course of
acute bronchopneumonia, a 20-year-old patient with CF
and bronchiolitis obliterans organizing pneumonia
(BOOP) (patient 2), and two patients, aged 12 and 17
years, with right sided pneumonectomy because of life-
threatening unilateral lung disease (patients 3 and 4).The
clinical courses of patients 2, 3 and 4 havebeendescribed
previously (11,17).
Clinical data of patientswith cystic ¢brosis
Sputum samples or deep throat swabs from children be-
low 5 years of age were evaluated for the presence of
Pseudomonas aeruginosa and Staphylococcus aureus. In pa-
tients aged 5 years or more, pulmonary function testing
was performed without prior bronchospasmolysis ac-
cording to the methods of Zapletal et al. (Bodytest II, E.
Jaeger GmbH, Wˇrzburg, Germany). The results were
expressed as a percentage of predicted values (18).
Lymphocyte phenotyping
Surface antigens were stained by means of the whole
blood technique recommendedby BectonDickinson Im-
munocytometry Systems (Heidelburg, Germany) whokindly provided antibodies for evaluation of normal va-
lues. In brief,100ml of whole blood were incubated with
20ml antibody suspension (20 minutes, room tempera-
ture). After ¢xation and lysis (FACSTM lysis solution,
10min, room temperature) the white blood cells were
washed (phosphatebu¡ered saline,10min, 300g) and re-
suspended in phosphate bu¡ered saline.The antibody pa-
nel consisted of antibodies against common surface
antigens of T (CD3), B (CD19), NK (CD16CD56), helper
(CD4) Tand suppressor/cytotoxic (CD8) T cells as well
as against theT cell activation markers interleukin-2 re-
ceptor (CD25, IL-2R) andHLA-DR antigen (MHCII class).
CD11b expression on CD8+ T cells distinguishes suppres-
soric (CD11b+) from cytotoxic (CD11bÿ) cells (19).
CD4+CD45RO+ cells are considered an activated and
short-life memory helperT cell subset that expresses IL-
2R, rapidly proliferates after antigen contact to e¡ector
T cells, and synthesizes cytokines. CD4+CD45RA+ cells
comprise naive helperT cells and a subset of quiescent,
long-life and slowly respondingmemory cells that devel-
op from CD4+CD45RO+ cells in the absence of antigen
contact (20). Antibody panels [FITC/PE (clone1/clone2)]:
IgG1 isotype control/IgG2 isotype control, CD45/CD14
(2D1/MFP9); CD3/CD19 (SK7/4G7); CD4/CD8 (SK3/
SK1); CD3/HLA-DR (SK7/L243); CD3/CD25 (SK7/2A3);
CD3/CD16CD56 (SK7/B73.1,MY31); CD8/CD11b (SK1/
D12); CD45RA/CD4 (L48/SK3); CD45RO/CD4 (UCHL-
1/SK3); (CD45RO, DAKO; all other antibodies: Becton
Dickinson). Two-colour £ow cytometry was performed
using a FACScan £ow cytometer calibrated with Cali-
BRITE beads and FACSComp software. For each test
tube at least15 000 white blood cells were analysed. For
all patients and controls the sum of relativeT (CD3+), B
(CD19+) andNK (CD16+CD56+) lymphocyte countswas
10075%. Automated data pre-analysis was performed
by means of SimulSETTM software, AttractorTM soft-
ware and quadrant statistics (FACScan £ow cytometer
and software, Becton Dickinson). Quadrants were de-
¢ned according to the £uorescence characteristics of
lymphocytes stained with £uorescence-conjugated,
non-speci¢c control antibodies. After automatic pre-
analysis by means of attractor gating, visual control of
all plots was performed. All values were expressed as
percentages of gated lymphocytes. Absolute counts
were recalculated from relative counts and absolute
white blood cell counts, analysed by means of a Coulter
MAXMs cell analyser.
Histopathology and immunohistochemistry
Haematoxylin^ eosin, Elastica van Gieson and immuno-
staining were performed on 4mm thick para⁄n sections
from lung tissue blocks. All tissue samples were immu-
nostained in parallel, using a routine protocol for an in-
direct peroxidase method with DAB as chromogen.
Sections from hyperplastic tonsils served as specimens
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following antibodies (antibodies: DAKO Hamburg,
Germany) were used [antigen speci¢city/clone (stained
cell populations)]: CD68/M814 (monocytes),CD20/M755
(B-cells), CD4/MT310 (helper T cells, monocytes), CD8/
M7103 (suppressoric/cytotoxic T cells), CD45RA/4KB5
(resting B cells, naiveT cells), CD56/MOC-1 (NK cells),
CD45RO/UCHL-1 (memoryT cells).
Statistical analysis
Although pediatric lymphocyte subsets are age-depen-
dent, for statistical analysis the data of all patients or
controlpersonsrespectively werepooled, and anoverall
analysis was performed, with a signi¢cance level of
Po0?001 being selected (two-tailed Mann^Whitney U-
test, SPSS software).This procedurewas not sensitive to
subtle changes, but aimed at detecting strong and age-
independent factors, reducing the experiment-wise
type-I error rate in the presence of many dependent
variables and a limited population size. Age-related
changes of LS in CF were summarized only in a descrip-
tive fashion, includingonlymajor LS and thosewhere sta-
tistical overall analysis had revealed signi¢cant changes.
Because the antibody panel was expanded during the
study period, data on CD11b expression were available
from 42 and on CD45RA/RO expression from 37 pa-
tients with CF only.
RESULTS
Clinical data of patientswith cystic ¢brosis
The high prevalence of P. aeruginosa-positive patients in
the ¢rst age group mirrors the preselection of severelyTABLE 1. Clinical data of the patients
age group1
(n=6)
1month^3 yrs
FEV1* notdone
FVC* notdone
Mean expiratory £ow
at 50% of vital capacity*
notdone
Mean expiratory £ow
at 25% of vital capacity*
notdone
TLC* notdone
Patient sputum
Pseudomonas aeruginosa-
positive
n=4 (66%)
Patient sputum
Staphylococcus aureus-
positive
n=1 (17%)
*Values expressed asmedian (25%^75% percentiles) (% of pred
FEV: forced expiratory volume in1sec;FVC: forcedvital capacity;diseased patients treated at our hospital (Table1). As ex-
pected, pulmonary function analysis revealed progres-
sion of lung diseasewith age.
Lymphocyte subsets in patientswith CF
Comparison of patients and controls revealed no di¡er-
ences between absolute white blood cell counts, mono-
cyte counts and neutrophil counts. Patients with CF,
however, showed a marked lowering of CD4+CD45RO+
(memory helper) cells, of T cells expressing IL-2R, of
CD8+ cells and of CD16+56+ NK cells (Po0?001;
Table 2). As can be hypothesized fromTable 3, the lower-
ing of distinctperipheral LSmay alreadyoccur at a young
age (CD4+CD45RO+) or progress with age
(CD8+CD11b+; suppressoric).
Patients with CF and P. aeruginosa and/or S. aureus in
sputum did not di¡er from the non-colonized patients
with respect to their lymphocyte subsets.
Lymphocyte subsets in patientswith
bronchopulmonary infections
Compared to healthy controls, patients with recurrent
bronchopulmonary infections showed similar changes
to those registered in patients with CF; i.e. a decrease
of CD4+CD45RO+ cells and of T cells expressing IL-2R
(Po0?001; data not shown).
Morphological changes in lung tissue
Patient 1 showed acute bronchopneumonia with intra-
alveolar granulocytes, no interstitial pneumonia, no lym-
phoid aggregates or follicles, and only very sparse lym-
phocytes. In patients 2, 3 and 4, lymphoid aggregatesage group 2
(n=8)
4^9 yrs
age group 3
(n=12)
10^15 yrs
age group 4
(n=18)
 16 years
91 (67^101) 73 (63^78) 53 (33^73)
90 (73^97) 71 (63^74) 66 (43^85)
74 (39^114) 56 (32^81) 25 (13^46)
44 (32^116) 38 (23^48) 19 (13^38)
100 (87^119) 92 (83^97) 96 (89^115)
n=3 (37?5%) n=9 (75%) n=13 (72?2%)
n=2 (25%) n=3 (25%) n=5 (27?2%)
ictedvalue).
TLC: totallungcapacity.
TABLE 2. Comparison of lymphocyte subsets betweenpatientswith CFand controls
Allpatientswith CF
age:1month^36 yrs
(n=44)
All controls
age:1month - 29 yrs
(n=83)
Signi¢cant
di¡erences
Leucocytes x10ÿ3mlÿ1 6?3 (4?9^7?9) 6?7 (5?4^8?7)
Lymphocytes x10ÿ3mlÿ1 1?9 (1?4^2?4) 2?5 (1?8^3?3)
CD3+ x10ÿ3mlÿ1 1?5 (1?1^1?8) 1?8 (1?3^2?6)
% CD3+ in lymph 76 (69^81) 69 (65^74) Po0?001
%HLA-DR+ in CD3+ 9 (6^11) 8 (6^12)
%CD25+ in CD3+ 11 (9^16) 15 (11^23)
CD3CD25+ x10ÿ3mlÿ1 0?19 (0?14^0?24) 0?3 (0?23^0?36) Po0?001
CD19+ x10ÿ3mlÿ1 0?28 (0?19^0?41) 0?38 (0?26^0?74)
% CD19+ in lymph 15 (12^18) 17 (13^21)
%CD16CD56+ in lymph 9 (6^13) 12 (9^15)
CD16CD56+ x10ÿ3mlÿ1 0?15 (0?11^0?27) 0?3 (0?23^0?39) Po0?001
CD4/CD8 ratio 1?5 (1?1^2) 1?2 (1^1?5)
CD8+ x10ÿ3mlÿ1 0?6 (0?4^0?8) 0?9 (0?6^1?2) Po0?001
%CD8+ in lymph 29 (24^36) 33 (28^38)
ratio CD11bÿ/CD11b+ in CD8+ 3?5 (2?3^5?9) 3 (2^4?4)
CD4+ x10ÿ3mlÿ1 0?9 (0?5^1?1) 1 (0?7^1?4)
%CD4+ in lymph 44 (38^50) 40 (35^46)
CD45RA+CD4+x10ÿ3mlÿ1 0?6 (0?3^0?8) 0?7 (0?4^1?1)
%CD45RA+ in CD4+ 63 (56^73) 60 (51^69)
CD45RO+CD4+x10ÿ3mlÿ1 0?4 (0?3^0?5) 0?7 (0?5^1) Po0?001
%CD45RO+ in CD4+ 49 (37^57) 57 (45^67)
Values expressed asmedian (25%^75% quartiles).
TABLE 3. Age-related description ofmajor lymphocyte subpopulations of patientswith CFand controls
Age group 1 (1month^3yrs) 2 (4^9yrs) 3 (10^15yrs) 4 (X16yrs)
Patientswith CF n=6 n=8 n=12 n=18
CD3+ x10ÿ3mlÿ1 2?9 (2?4^3?7) 1?6 (1?5^1?7) 1?4 (1?3^1?9) 1?2 (0?8^1?7)
% CD3+ in lymph 76 (61^81) 74 (66^79) 77 (66^84) 76 (70^81)
CD3CD25+ x10ÿ3mlÿ1 0?23 (0?16^0?3) 0?19 (0?14^0?22) 0?2 (0?12^0?22) 0?17 (0?13^0?24)
CD4+ x10ÿ3mlÿ1 2?1 (1?7^2?2) 1 (0?9^1?1) 0?8 (0?6^1) 0?6 (0?4^0?9)
CD45RO+CD4+x10ÿ3mlÿ1 0?4 (0?3^0?6) 0?4 (0?4^0?5) 0?4 (0?3^0?6) 0?4 (0?3^0?5)
CD8+ x10ÿ3mlÿ1 0?9 (0?6^1?9) 0?6 (0?5^0?7) 0?7 (0?4^0?8) 0?4 (0?4^0?6)
ratio CD8+11bÿ/CD8+CD11b+ 2?9 (1?8^7) 3?1 (2?7^3?5) 4 (1?8^7?6) 4?7 (2?8^6?2)
CD19+ x10ÿ3mlÿ1 0?4 (0?2^1?3) 0?4 (0?3^0?6) 0?3 (0?1^0?5) 0?2 (0?2^0?3)
CD16CD56+ x10ÿ3mlÿ1 0?29 (0?13^1?1) 0?23 (0?14^0?27) 0?16 (0?11^0?27) 0?1 (0?14^0?26)
Controls n=17 n=21 n=19 n=26
CD3+ x10ÿ3mlÿ1 3?4 (2?8^4?6) 2 (1?5^2?6) 1?5 (1?2^1?9) 1?4 (1?1^1?7)
% CD3+ in lymph 67 (63^74) 68 (65^73) 69 (68^74) 71 (66^77)
CD3CD25+ x10ÿ3mlÿ1 0?27 (0?29^0?37) 0?29 (0?22^0?33) 0?23 (0?17^0?28) 0?38 (0?33^0?49)
CD4+ x10ÿ3mlÿ1 2?4 (1?7^3?2) 1?1 (0?8^1?4) 0?8 (0?6^1) 0?9 (0?7^1?1)
CD45RO+CD4+x10ÿ3mlÿ1 1?1 (0?8^1?2) 0?8 (0?5^1) 0?5 (0?4^0?6) 0?7 (0?5^0?8)
CD8+ x10ÿ3mlÿ1 1?2 (1^1?7) 0?9 (0?7^1?2) 0?8 (0?6^1) 0?7 (0?5^0?9)
ratio CD8+11bÿ/CD8+CD11b+ 4?7 (2?7^6?6) 2?9 (1?9^4?5) 3?7 (2?8^4?4) 2?3 (1?6^2?9)
CD19+ x10ÿ3mlÿ1 1?2 (1^1?9) 0?5 (0?3^0?7) 0?4 (0?3^0?5) 0?2 (0?2^0?3)
CD16CD56+ x10ÿ3mlÿ1 0?36 (0?27^0?77) 0?32 (0?24^0?46) 0?28 (0?25^0?37) 0?25 (0?18^0?35)
Values expressed asmedian (25%^75% quartiles).
90 RESPIRATORYMEDICINEand follicleswereprominent and located in thebronchial
submucosa. As described previously, lung tissue of pa-
tient 2 showed the characteristics of BOOP (11).Lung tis-
sue of patients 3 and 4 furthermore showed areas ofabscess formation, areas of preserved alveolar architec-
ture with or without alveolar septal thickening, and
areas of ¢brous scarring. Numerous foamy alveolar
macrophages were found within alveoli. Macrophages
LYMPHOCYTESUBSETS INCYSTICFIBROSIS 91andneutrophilswere abundant inside abscess formations
butvirtually absent from interstitial tissue. In accordance
with the literature (21), three compartments of intersti-
tial lymphocyte in£ammation could be de¢ned: alveolar
septa, the bronchial subepithelial and submucous layer,
and bronchus-associated lymphoid tissue (BALT) with
lymphoid aggregates and lymphoid follicles; the latter
consisting of the follicular area bounded by the parafolli-
cular area and the dome area [Fig. 2(a), (b)].Compared to
patients 3 and 4, interstitial in£ammationwasmore pro-
nounced in patient 2 inwhom abscess formationwas ab-
sent.
In patient1, the sparse andrandomlydistributed inter-
stitial lymphocytes consisted of CD45RA+- and CD4+-T
cells.CD20+B cellswerevirtually absent frominterstitial
tissue. Notable and randomly distributed interstitial
CD56+ cell in¢ltrations were found in this patient only,
whereas CD8+ and CD45RO+ cells were not found. In
patients 2, 3 and 4,T cells weremost prominent in paraf-
ollicular areas, but were also found in follicular areas
forming aggregates, in dome areas, in alveolar septa and
in thebronchial subepithelium.Thevastmajorityof these
T cells were CD4+ and CD45RO+ [Fig. 2(a)]. Notable
CD8+ cell counts were found only in parafollicular areas
and in the bronchial subepithelial layer of patient 2.
CD20+ B cells were dominant and randomly distributed
in follicular areas. Less frequent CD20+ B cell counts
were found in the dome and parafollicular areas, and in
the submucous tissue adjacent to lymphoid follicles. Rare
CD20+ B cell counts were also recorded in the bronchial
subepithelium [Fig. 2(b)].Marked plasma cell in¢ltrations
(CD20ÿ) were found in the bronchial subepithelium.
Plasma cells were surrounded by CD4+ and CD45RO+
T cells.CD45RA+ cells (resting B cells, naiveT cells) were
found in follicular areas only.0
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FIG. 1. Decrease of memory helperT cells (CD4+CD45RO+) in
chemistry of lung tissue was performed (*, several measureme
patients with CF, absolute counts of CD45RO+ helperT cells are
absolute counts of CD4+CD45RA+ (na|«ve helper) T cellswere norDISCUSSION
This investigation is the ¢rst to demonstrate a marked
decrease of peripheral CD4+CD45RO+ memory helper
T cells and of NK cells in a larger group of patients with
CF (Table 2). Additionally, considering the severe lung in-
fection and theknown increase of soluble Il-2R inCF ser-
um (22), we found an astonishingly low expression of the
activation marker IL-2R on T cells. Neutrophils and
monocytes, in contrast, were not a¡ected in a compar-
able fashion, although these LS dominate the intrabron-
chial in£ammation. Hypothetically, shedding of CD4 and
CD8 surface antigens by neutrophil exoenzymes might
decrease surface antigen density, impair £ow-cytometric
detection andmimic a decrease of distinct LS.However,
in patients with CF, shedding has been shown to be re-
stricted to the airway lumen (16); to exclude this bias,
only patients in a stable clinical condition were enrolled.
CD4 shedding should also have a¡ected CD4+CD45RA+
cell counts, which were normal, and histopathology re-
vealed a high submucous CD4+ cell density where CD4
shedding should have been most extensive. Therefore,
the observed ¢ndings can be assumed to indicate a spe-
ci¢c decrease of distinct peripheral LS.
One cause for this decreasemight be a suppression of
the lymphocyte system due to the extensive intrabron-
chial neutrophil in£ammation, a hypothesis controver-
sially discussed in the literature. On the one
hand, investigation of peripheral blood lymphocytes
revealed a depressed in-vitro B and T cell response to
mitogen stimulation and a reduced T cell cytotoxicity
(6,23^26). These ¢ndings were more severe in patients
with advanced lung disease and agreewith the observed
peripheral lowering of activated lymphocytes. On the
other hand, hypergammaglobulinemia with high anti-20 25 30 35 40
Age (years)
83 controls (*), in the three older patients where immunohisto-
nts per patient), and in the remaining 41 patients with CF (&). In
low. A similar lowering was observed for IL-2R+ T cells, whereas
mal (Table 2).
FIG. 2. (a) Lung tissue stained for CD45RO+ T cells.Marked accumulation of CD45RO+ T cells in the parafollicular area (P), in the
domearea (D) andininterstitialtissue (J).CD45RO+T cell aggregates arepresentinfollicular areas (arrow).Bar:150 mm. (b) Lung tissue
stained for CD20+ B cells.CD20+ B cells are found predominantly in follicular areas (F), but are also present in parafollicular areas, in
the dome areas, in the submucous tissue adjacentto lymphoid follicles (arrow) and, to a much lesser extent, in the subepithelial layer.
Bar: 200 mm.
92 RESPIRATORYMEDICINEbody titres to P. aeruginosa exoenzymes is characteristic
of CF (1^3), and immunosuppressive treatment with ibu-
profen or steroids improves lung function of patients
with CF (27).Homing to pulmonary tissue may be a further expla-
nation for the decrease of distinct peripheral LS.This hy-
pothesis is supported by our histopathologic ¢ndings,
showing CD4+CD45RO+ T cells aggregated within lym-
LYMPHOCYTESUBSETS INCYSTICFIBROSIS 93phoid follicles, scattered throughout the interstitial
spaces and surrounding submucous plasma cells in the
three older patients [Fig. 2(a), (b)]. As CD45RO+ T cells
account for themajorityof peripheral IL-2R+T cells (28),
pulmonary pooling of this LSwould also explain the per-
ipheral decrease of IL-2R+ T cells. However, due to the
limitednumberof tissue specimens available and thepre-
selection of our patients, this hypothesis remains to be
veri¢ed in the course of further, more extensive studies.
Moreover, CD8+ and NK cells, that were low in periph-
eral blood, were not increased in lung tissue although
these LS may be important for immune defense (29,30)
against P. aeruginosa. Possibly, CD8+ cells migrate to the
airway lumenwhere they are lostduring immune defense
or becomeundetectable after CD8 antigen cleavage (16).
NK and CD8+ cells might also be more frequent in lung
tissue of patientswith less severebacterial in£ammation:
NK cells, for instance, were present in patient 1 where
chronic lung disease was absent, and CD8+ cells were
present in the patient with bronchiolitis obliterans orga-
nizing pneumonia (patient 2). Interstitial CD8+ cells have
also been described in lung tissue of a patient with aller-
gic bronchopulmonary aspergillosis and CF (5).
Neither the decrease of peripheral blood LS nor the
observed interstitial lymphocyte distribution, however,
can be considered CF-speci¢c. Although lung disease
had been present for a short period of time only, our
non-CF patients with recurrent bronchopulmonary in-
fections showed a decrease of peripheral
CD4+CD45RO+ and of IL-2R+ T cells.Moreover, the im-
munohistochemical ¢ndings of the cases reported here
share the typical characteristics of activated BALT,
which is not observed in healthy adults (31), but is known
from di¡erent in£ammatory pulmonary diseases such as
asthma, sarcoidosis or chronic hypersensitivity pneumo-
nitis (13,14,21). In patients with sarcoidosis and asthma,
even a secondary decrease of peripheral CD4+ and
CD8+ cells may occur (13,14). In patients with chronic hy-
persensitivity pneumonitis, where interstitial CD8+ cell
accumulation is not found either (21), repeated exposure
to organic inhalation antigens leads to similar complica-
tions as known from patients with CF; i.e. persistent
small airway in£ammation, interstitial ¢brosis and
bronchiolitis obliterans organizing pneumonia. In a com-
parable fashion, ongoing intrabronchial Pseudomonas
antigen challengemay stimulate cytokine synthesis in CF
bronchial epithelial and intrabronchial in£ammatory
cells, establish a Th2-type cytokine milieu, initiate and
maintain the interstitial accumulation andperipheral de-
crease of highly activated lymphocytes, and contribute
to pulmonary complications (10,11). Pseudomonas exoen-
zyme S may even directly activate CD4+ cells (32) and
enhance this process. Considering these mechanisms
and the high impact of P. aeruginosa for lung disease in
CF, it seems astonishing that patients with or without
Pseudomonas colonization did not di¡er with respect totheir peripheral LS.However, the absence of P. aeruginosa
from sputum samples does not rule out its presence
from small airways, and further factors that have not
been taken into account in the present study, such as vir-
al pulmonary infections, may also in£uence the in£am-
matory process (33).
Further studies on larger patient populations and
numbers of lung tissue specimens are needed to specify
the relationship between changes of distinct peripheral
blood lymphocyte subsets, pulmonary infection and in-
terstitial pneumonia. These studies should also investi-
gate whether the decrease of distinct peripheral blood
LS progresses with the age of the patients and the de-
cline of pulmonary function. Possibly, immunophenotyp-
ing of peripheral blood LS will become a useful indirect
tool for assessment of interstitial pulmonary in£amma-
tion in CF.
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